395. Early Predictors of Intensive Care Unit Admission among COVID-19 Patients in Qatar

Author:

Abuyousef Safae1,Alnaimi Shaikha2,Omar Nabil E3,Elajez Reem4,Elmekaty Eman Zeyad Ibrahim4,Abdelfattah-Arafa Eiman4,Barazi Raja4,Ghasoub Rola5,Rahhal Ala4,Hamou Fatima4,Al-Amri Maha K4,Karawia Ahmed4,Ajaj Fatima6,Alkhawaja Raja7,Kardousha Ahmed4,Awaisu Ahmed8,Abou-Ali Adel9,Khatib Mohamad10,AbouKamar Mohamed4,Al-Hail Moza11

Affiliation:

1. Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar, Doha, Ad Dawhah, Qatar

2. Department of Pharmacy, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

3. Pharmacy Department, National center for cancer care and research, Hamad Medical Corporation, Qatar, Doha, Ad Dawhah, Qatar

4. Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

5. ncccr, doha, Al Khawr, Qatar

6. Home Health Care, Hamad Medical Corporation, Doha, Qatar, doha, Ad Dawhah, Qatar

7. Department of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, Doha, Ad Dawhah, Qatar

8. College of Pharmacy, Qatar University, Doha, Ad Dawhah, Qatar

9. Astellas Pharma Global Development, Inc., Northbrook, Illinois

10. Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar, Doha, Ad Dawhah, Qatar

11. Hamad Medical Corpoartion, Doha, Ad Dawhah, Qatar

Abstract

Abstract Background Coronavirus disease (COVID-19) is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission and in-hospital mortality among patients diagnosed with COVID-19. Methods This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29 - May 29, 2020. For each case enrolled, one control was matched by age and gender. Results A total of 1560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (CVD) (adjusted odds ratio (aOR)=1.64, 95% confidence interval (CI): 1.16 - 2.32, p=0.005), diabetes (aOR=1.52, 95% CI: 1.08 - 2.13, p= 0.016), obesity (aOR=1.46, 95% CI: 1.03-2.08, p= 0.034), lymphopenia (aOR=2.69, 95% CI: 1.80-4.02, p< 0.001), high aspartate aminotransferase (AST) (aOR= 2.59, 95% CI: 1.53-4.36, p< 0.001), high ferritin (aOR=1.96, 95% CI: 1.40-2.74, p< 0.001), high C-reactive protein (CRP) (aOR=4.09, 95% CI: 2.81-5.96, p< 0.001), and dyspnea (aOR=2.50, 95% CI: 1.77-3.54, p< 0.001). Similarly, significant predictors of mortality included CVD (aOR=2.16, 95% CI: 1.32- 3.53, p=0.002), diabetes (aOR=1.77, 95% CI: 1.07-2.90, p=0.025), cancer (aOR=4.65, 95% CI: 1.50-14.42, p= 0.008), lymphopenia (aOR=2.34, 95% CI: 1.45-3.78, p= 0.001), and high AST (aOR= 1.89, 95% CI: 1.04-3.43, p=0.036). Risk Factors for ICU admission among patients with COVID-19 (N=1560) Conclusion Having CVD, diabetes, lymphopenia, and increased AST were independent predictors for both ICU admission and in-hospital mortality in patients with COVID-19. In addition, obesity, high ferritin, and CRP levels were associated with increased risk of ICU admission, while cancer was strongly associated with in-hospital mortality. Early identification and monitoring of patients at risk is essential in planning the level of care needed to prevent delay in medical intervention. Disclosures Adel Abou-Ali, PharmD, PhD, Astellas Pharma Global Development, Inc. (Employee)

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3